The global metildigoxin market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing incidence of heart disease across the globe due to unhealthy eating habits, sedentary lifestyles, and many others. According to NHANES, in 2018, the prevalence of CVD was around 49.2% that will fuel the growth of the market during the forecast period.

Metildigoxin is used for the treatment of acute and chronic heart failure and cardiac arrhythmia. It is a semisynthetic cardiac glycoside that is converted into digoxin after oral administration. The injectable form of the drug is administered by slow intravenous infusion and the dose is tailored according to each individual and the severity of the disease. With the increasing prevalence of CVD due to factors like smoking, pollution, stress, and many others it is estimated that the demand will grow for the metildigoxin during the forecast period. 

The drug Metildigoxin is also used for the treatment of congestive heart failures in the dog, as well as many other heart conditions. The drug may go by the brand name of Cardoxin or Lanoxin for the treatment in dogs. The function of the drug in dogs is by increasing the level of calcium in the heart, which helps in muscle contraction. This strengthens the heartbeat, increases the amount of blood flow and reduces the fluid build up in the lungs. The drug is also used for various other conditions such as atrial fibrillation, cardiac arrhythmias, and many others in dogs. With the increasing adoption of pets across the globe, this factor will fuel the growth of the market during the forecast period. Some of the key global players in the global metildigoxin market include Centroflora, Tianjin Kaiwei and Young United Chemical, Kemprotec, and many others.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Application 

    • Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape -Centroflora, Tianjin Kaiwei and Young United Chemical, Kemprotec.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global MetildigoxinMarket by Segments

By Type

    • Tablet

    • Injection

    • Other 

By Application 

    • Cardiac

    • Other

Global Metildigoxin Market by Region

North America       

    • US 

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa